Davar Quoted in BioWorld on Enforcement Discretion for Digital Health

Life Sciences & Healthcare Regulatory partner Mahnu Davar was quoted in a recent article from BioWorld, "FDA Enforcement Discretion for Digital Health a Source of Uncertainty for Industry." The article discusses the FDA's current approach to enforcing digital health technologies, as well as the agency's plans to clarify policies related to the regulation of health software.

» Read the full article (subscription required)